A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples